PlainPill

Mescaline

People mainly take Mescaline for mood. Based on 5 first-hand reports and 16 meta-analyses & systematic reviews in the medical literature. Ranked #829 of 1,974 overall.

20
User score
Mostly positive
40% positive0% mixed0% negative60% unclear

Of reports that state an outcome, 100% are positive.

Clinical research
BModerate research base
16
meta-analyses
7
RCTs
982
papers

What Mescaline does, according to users

Of the people who reported each effect, the share who said it got better.

betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

BModerate research base

At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.

Expert Opin Pharmacother · 2023 · Meta-analysis / systematic review
Psychedelics for treatment resistant depression: are they game changers?

Conclusion: Nevertheless, further adequately powered, double-blind, comparator-controlled trials are required to explore and clarify the mechanisms of action and long-term effects of psychedelics in TRD. Psychedelics also hold promise for other psychiatric conditions, such as bipolar depression and post-traumatic stress disorder.

PubMed 37947195 ↗
J Subst Abuse Treat · 2022 · Meta-analysis / systematic review
A systematic literature review of clinical trials and therapeutic applications of ibogaine

Conclusion: Treatment of SUDs and persisting comorbidities requires innovative treatment approaches. Rapid-onset therapies such as the application of ibogaine may offer novel treatment opportunities for specific individuals. Rigorous study designs within medical settings are necessary to warrant safe application, monitoring, and, possibly, medical intervention.

PubMed 35012793 ↗
Neurosci Biobehav Rev · 2016 · Meta-analysis / systematic review
Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

Conclusion: Long-term use was associated with thinning of the posterior cingulate cortex, thickening of the anterior cingulate cortex, and decreased neocortical 5-HT2A receptor binding. Despite the high methodological heterogeneity and the small sample sizes, the results suggest that hallucinogens increase introspection and positive mood by modulating brain activity in the fronto-temporo-parieto-occipital cortex.

PubMed 27810345 ↗
Mol Psychiatry · 2026 · Meta-analysis / systematic review
Psychedelic-induced hypomania and mania: a systematic review and meta-analysis

Conclusion: Overall, serotonergic psychedelics appear to pose a low but clinically meaningful relative risk of transient mood-related symptoms in susceptible individuals while remaining relatively safe in controlled clinical settings. Long-term outcomes and repeated exposure remain insufficiently studied, underscoring the need for rigorous longitudinal research.

PubMed 42215638 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

microdoseas reported
3-4 gas reported

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“Personally I'd recommend mescaline for a first psychedelic experience”
Source discussion ↗
“Microdoses are pretty much a cure for autism for me. If I'm on a microdose of LSD or mescaline, I have perfect days, utterly perfect.”
Source discussion ↗
“Mescaline / Methylscalline seem to be useful too”
Source discussion ↗
Top discussions (3)

Other options for mood

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate